Istaroxime, a Stimulator of Sarcoplasmic Reticulum Calcium Adenosine Triphosphatase Isoform 2a Activity, as a Novel Therapeutic Approach to Heart Failure

American Journal of Cardiology

Volumn 99, Issue 2 SUPPL., 2007, Pages

  Micheletti, Rosella ^a   Palazzo, Fiorentina ^a   Barassi, Paolo ^a   Giacalone, Giuseppe ^a   Ferrandi, Mara ^a   Schiavone, Antonio ^a   Moro, Barbara ^a   Parodi, Oberdan ^b   Ferrari, Patrizia ^a   Bianchi, Giuseppe ^c  

^a Prassis Sigma Tau Research Institute   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ADENOSINE TRIPHOSPHATASE 2A; CALCIUM; ISOENZYME; ISTAROXIME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITOR INTERACTION; FLOW RATE; GUINEA PIG; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE RELAXATION; HEART VENTRICLE OVERLOAD; HUMAN; HUMAN TISSUE; INOTROPISM; MICROSOME; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

ANIMALS; CARDIOTONIC AGENTS; ENZYME ACTIVATION; ETIOCHOLANOLONE; GUINEA PIGS; HEART FAILURE, CONGESTIVE; HUMANS; MUSCLE, SMOOTH, VASCULAR; NA(+)-K(+)-EXCHANGING ATPASE; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 33846247498     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.09.003     Document Type: Article

References (33)

1. Gheorghiade M., Zannad F., Sopko G., Klein L., Piña I.L., Konstam M.A., Massie B.M., Roland E., Targum S., Collins S.P., Filippatos G., Tavazzi L., and International Working Group on Acute Heart Failure Syndromes. Current state and framework for future research. Circulation 112 (2005) 3958-3968
2. Bayram M., De Luca L., Massie B., and Gheorghiade M. Dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes: a reassessment. Am J Cardiol 96 suppl 6A (2005) 47G-58G
3. Nieminen M.S., and Harjola V.P. Definition and epidemiology of acute heart failure syndromes. Am J Cardiol 96 suppl 6A (2005) 5G-10G
4. Gheorghiade M., Gattis Stough W., Adams K.F., Jaffe A.S., Hasselblad V., and O'Connor C.M. The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVED-HF). Am J Cardiol 96 suppl 6A (2005) 18G-25G
5. Hasenfuss G., and Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol 34 (2002) 951-969
6. 2+ handling in heart failure. J Clin Invest 115 (2005) 556-564
7. Davies C.H., Davia K., Bennett J.G., Pepper J.R., Poole-Wilson P.A., and Harding S.E. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92 (1995) 2540-2549
8. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., and Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
9. Reiken S., Wehrens X.H.T., Vest J.A., Barbone A., Klotz S., Mancini D., Burkhoff D., and Marks A.R. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107 (2003) 2459-2466
10. Lehnart S.E., Wehrens X.H.T., Laitinen P.J., Reiken S.R., Deng S.-X., Cheng Z., Landry D.W., Kontula K., Swan H., and Marks A.R. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109 (2004) 3208-3214
11. Bers D.M. Excitation-Contraction Coupling and Cardiac Contractile Force (2001), Kluwer Academic Publishers, Dordrecht, Netherlands 277-279
12. Meyer M., Schillinger W., Pieske B., Holubarsch C., Heilmann C., Posival H., Kuwajima G., Mikoshiba K., Just H., and Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92 (1995) 778-784
13. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 37 (1998) 279-289
14. 2+-sensitivity of SERCA2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol 31 (1999) 479-491
15. O'Rourke B., Kass D.A., Tomaselli G.F., Kaab S., Tunin R., and Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. I: experimental studies. Circ Res 84 (1999) 562-570
16. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 85 (1999) 1009-1019
17. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99 (1999) 641-648
18. Weber C.R., Piacentino III V., Houser S.R., and Bers D.M. Dynamic regulation of sodium/calcium exchange function in human heart failure. Circulation 108 (2003) 2224-2229
19. Muller O.J., Lange M., Rattunde H., Lorenzen H.P., Muller M., Frey N., Bittner C., Simonides W., Katus H.A., and Franz W.M. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res 59 (2003) 380-389
20. Freeman K., Lerman I., Kranias E.G., Bohlmeyer T., Bristow M.R., Lefkowitz R.J., Iaccarino G., Koch W.J., and Leinwand L.A. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J Clin Invest 107 (2001) 967-974
21. Iwanaga Y., Hoshijima M., Gu Y., Iwatate M., Dieterle T., Ikeda Y., Date M., Chrast J., Matsuzaki M., Peterson K.L., Chien K.R., and Ross Jr. J. Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J Clin Invest 113 (2004) 727-736
22. + channel in rat arterial myocytes. Eur J Pharmacol 333 (1997) 249-259
23. Hasenfuss G., Pieske B., Castell M., Kretschmann B., Maier L.S., and Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 98 (1998) 2141-2147
24. Parissis J.T., Panou F., Farmakis D., Adamopoulos S., Filippatos G., Paraskevaidis L., Venetsanou K., Lekakis J., and Kremastinos D.T. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure. Am J Cardiol 96 (2005) 423-426
25. 2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes. Eur J Pharmacol 435 (2002) 27-33
26. + pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride]. J Pharmacol Exp Ther 313 (2005) 207-215
27. Micheletti R., Mattera G.G., Rocchetti M., Schiavone A., Loi M.F., Zaza A., Gagnol R.J., De Munari S., Melloni P., Carminati P., Bianchi G., and Ferrari P. Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744). J Pharmacol Exp Ther 303 (2002) 592-600
28. 2+-release channels: a possible role in cardiac inotropy. Br J Pharmacol 108 (1993) 1043-1050
29. Sagawa T., Sagawa K., Kelly J.E., Tsushima R.G., and Wasserstrom J.A. Activation of cardiac ryanodine receptors by cardiac glycosides. Am J Physiol 282 (2002) H1118-H1126
30. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., et al., American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
31. 2+ cycling in isolated failing human myocardium. Circulation 105 (2002) 194-199
32. Jones L.R., Besch Jr. H.R., Fleming J.W., McConnaughey M.M., and Watanabe A.M. Separation of vesicles of cardiac sarcolemma from vesicles of cardiac sarcoplasmic reticulum: comparative biochemical analysis of component activities. J Biol Chem 254 (1979) 530-539
33. Lehnart S.E., Schillinger W., Pieske B., Prestle J., Just H., and Hasenfuss G. Sarcoplasmic reticulum proteins in heart failure. Ann N Y Acad Sci 853 (1998) 220-230